Sara Mason
Physician Assistant · Omaha, NENPI 1013573260
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 741 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 741 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$920
- Vanda Pharmaceuticals Inc.$794
- Johnson & Johnson$698
- Otsuka America Pharmaceutical, Inc.$672
- plus $6K from 28 others
What the payments were for
- Food & beverage$11,50298%
- Education$2462%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 151 | $1,914 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 69 | $1,068 |
| Alkermes, Inc. | 64 | $920 |
| Vanda Pharmaceuticals Inc. | 41 | $794 |
| Johnson & Johnson | 36 | $698 |
| Otsuka America Pharmaceutical, Inc. | 38 | $672 |
| Teva Pharmaceuticals USA, Inc. | 40 | $659 |
| Harmony Biosciences LLC | 35 | $562 |
| Lundbeck LLC | 31 | $511 |
| Axsome Therapeutics, Inc. | 29 | $492 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $434 |
| Supernus Pharmaceuticals, Inc. | 23 | $404 |
| Corium, LLC | 22 | $361 |
| Jazz Pharmaceuticals Inc. | 16 | $274 |
| Sunovion Pharmaceuticals Inc. | 16 | $265 |
| Ironshore Pharmaceuticals Inc. | 15 | $248 |
| E.r. Squibb & Sons, L.L.C. | 11 | $214 |
| Neurocrine Biosciences, Inc. | 8 | $153 |
| Tris Pharma Inc | 8 | $147 |
| Neos Therapeutics, LP | 9 | $142 |
| Idorsia Pharmaceuticals US Inc | 6 | $111 |
| Avanir Pharmaceuticals, Inc. | 8 | $111 |
| Bausch Health US, LLC | 5 | $96 |
| Almatica Pharma LLC | 6 | $95 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| Noven Therapeutics, LLC | 4 | $67 |
| Eisai Inc. | 4 | $58 |
| Biogen | 2 | $46 |
| Alfasigma USA, Inc. | 2 | $42 |
| Pfizer | 2 | $31 |
| Merck | 2 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$133
How this compares
$11,748 in reported general payments places this provider in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 14 | $24,922 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 24 | $2,175 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 45 | $1,365 |
| Alprazolam ErAlprazolam | 25 | $1,150 |
| Aripiprazole | 47 | $1,031 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 11 | $1,014 |
| Mirtazapine | 49 | $817 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 43 | $726 |
| Trazodone Hcl | 40 | $667 |
| Bupropion XlBupropion Hcl | 20 | $522 |
| Gabapentin | 43 | $432 |
| Buspirone Hcl | 11 | $393 |
| Lorazepam | 62 | $343 |
| Quetiapine Fumarate | 29 | $334 |
| Eszopiclone | 13 | $279 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,914 | $24,92214 claims |
| Almatica Pharma LLCSertraline Hcl | $95 | $13914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Other physician assistant in Omaha
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Christopher BeasleyOmaha$15K
- Corrine GiggeeOmaha$12K
- Austin DuerksenOmaha$12K
- Erin HoffmanOmaha$12K
- Sally CampbellOmaha$9K
- Angela KlineOmaha$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.